MedPath
HSA Approval

E-Z-GAS II GRANULES

SIN06442P

E-Z-GAS II GRANULES

E-Z-GAS II GRANULES

July 11, 1991

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

GRANULE

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

DCH AURIGA SINGAPORE

Tower Laboratories

Active Ingredients

SIMETHICONE

0.04 g/4 g

Simethicone

CITRIC ACID

1.54 g/4 g

Citric acid

SODIUM BICARBONATE

2.22 g/4 g

Sodium bicarbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

E-Z-GAS II GRANULES - HSA Approval | MedPath